AstraZeneca PLC's 2019 net prices on average across the portfolio will decrease versus 2018, although the company will take price increases on some products, Senior VP-Market Access Rick Suarez said in an interview at J.P. Morgan.
The industry is under pressure from the public and legislators when it comes to list price increases. HHS Secretary Alex...








